Depression at antiretroviral therapy initiation and clinical outcomes among a cohort of Tanzanian women living with HIV.

Journal: AIDS (London, England)

Volume: 31

Issue: 2

Year of Publication: 2018

Affiliated Institutions:  aDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA bDepartment of Psychiatry and Mental Health cDepartment of Internal Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania dDepartment of Epidemiology eDepartment of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA fDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania gDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Abstract summary 

The objective of the study was to assess the relationship of depression at antiretroviral therapy (ART) initiation with mortality and clinical outcomes among Tanzanian women living with HIV.We conducted a prospective cohort study of 1487 women who initiated ART in Dar es Salaam, Tanzania.Symptoms of depression and anxiety were assessed using a Tanzanian-adapted and validated version of the Hopkins Symptom Checklist. Participants attended monthly clinic visits during the first 2 years of ART and CD4 T-cell counts were assessed every 4 months. Proportional hazard models were used to assess the relationship of depression with mortality and clinical outcomes.Symptoms consistent with depression were prevalent among 57.8% of women at ART initiation. After multivariate adjustment, including social support and stigma, depression at ART initiation was associated with increased risk of mortality [hazard ratio (HR): 1.92; 95% confidence interval (CI): 1.15-3.20; P = 0.01] and incidence of severe anemia (hemoglobin <8.5 g/dl; HR: 1.59; 95% CI: 1.07-2.37; P = 0.02). Under the assumption of causality, we estimate 36.1% (95% CI: 13.6-55.1%) of deaths among the study cohort were attributable to depression and its consequences. Depression was not significantly associated with trajectory of CD4 T-cell reconstitution or the risk of immunologic failure (P values >0.05).Elimination of depression may reduce mortality during the first 2 years of ART by one-third in our study cohort. Randomized trials and rigorous implementation studies are needed to evaluate the individual and population-level effects of integrated mental health interventions and HIV treatment approaches in resource-limited settings.

Authors & Co-authors:  Sudfeld Christopher R CR Kaaya Sylvia S Gunaratna Nilupa S NS Mugusi Fedinand F Fawzi Wafaie W WW Aboud Said S Smith Fawzi Mary C MC

Study Outcome 

Source Link: Visit source

Statistics
Citations :  UNAIDS. The gap report. Geneva: UNAIDS; 2014.
Authors :  7
Identifiers
Doi : 10.1097/QAD.0000000000001323
SSN : 1473-5571
Study Population
Women
Mesh Terms
Adult
Other Terms
Study Design
Cohort Study,Randomized Control Trial
Study Approach
Country of Study
Tanzania
Publication Country
England